Vertex Pharmaceuticals
VRTX
NASDAQ
IPO1991
about VRTX
Vertex Pharmaceuticals is a biotechnology company dedicated to developing life-saving medicines, particularly for cystic fibrosis and other rare diseases, by targeting the underlying genetic causes rather than just symptoms.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $474.09 | $478.74 | $469.50 | $120.3B | 411.13K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$4.24 | 32.51 | 39.99 | 38.56% | 35.20% | 0% |